Europe Radiotherapy Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024
The Europe Radiotherapy Market has accounted for USD 1.6 billion in 2016, and is expected to reach USD 2.7 billion by 2024, and is growing at a CAGR 6.7% during the forecast period 2017 to 2024.
Cancer is the major cause of death in the world and the number of new patients each year is steadily increasing. The most common form of cancer mortality is by metastasis, where the tumors and cancerous cells spread to organs causing failure. The world is focused upon developing solutions and cure to cancer by destroying primary and secondary tumors that cause metastasis.
The key market players for Europe Radiotherapy Market are listed below:
The LDR segment is expected to account for the largest share of the internal radiotherapy/brachytherapy market, whereas the HDR segment is poised to witness the highest growth.
Based on product type the Europe radiotherapy market is segmented into EBRT equipment’s, and IBRT equipment’s.
The External Beam Radiotherapy (EBRT) products are further segmented into cyberknife, gammaknife, LINAC, Proton Beam (Cyclotron, Synclotron).
The Internal Beam Radiotherapy (IBRT) is segmented into seeds, afterloaders and others.
The Europe radiotherapy market is also segmented based on indication into cancer of different organs such as brain tumor, spine cancer, lung cancer, liver cancer, breast cancer, prostate cancer and others.
Based on geography, the Europe Radiotherapy market is segmented into 11 geographical regions, such as,
The report covers the present scenario and the growth prospects of the Europe Radiotherapy market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Cancer is the major cause of death in the world and the number of new patients each year is steadily increasing. The most common form of cancer mortality is by metastasis, where the tumors and cancerous cells spread to organs causing failure. The world is focused upon developing solutions and cure to cancer by destroying primary and secondary tumors that cause metastasis.
The key market players for Europe Radiotherapy Market are listed below:
- Varian Medical Systems, Inc.,
- CIVCO Medical Solutions,
- Elekta AB,
- Nanobiotix,
- Accuray Incorporated,
- Brainlab AG,
- Ion Beam Applications SA,
- C. R. Bard, Inc.,
- IsoRay Medical, Inc.,
- TRF, Nordion, Inc.,
- RaySearch Laboratories AB,
- PRECISIS AG,
- Mevion Medical Systems, Inc.,
- Mitsubishi Electric Corporation
- Therapy
- Product
- Application
- Product Type
- Geography
The LDR segment is expected to account for the largest share of the internal radiotherapy/brachytherapy market, whereas the HDR segment is poised to witness the highest growth.
Based on product type the Europe radiotherapy market is segmented into EBRT equipment’s, and IBRT equipment’s.
The External Beam Radiotherapy (EBRT) products are further segmented into cyberknife, gammaknife, LINAC, Proton Beam (Cyclotron, Synclotron).
The Internal Beam Radiotherapy (IBRT) is segmented into seeds, afterloaders and others.
The Europe radiotherapy market is also segmented based on indication into cancer of different organs such as brain tumor, spine cancer, lung cancer, liver cancer, breast cancer, prostate cancer and others.
Based on geography, the Europe Radiotherapy market is segmented into 11 geographical regions, such as,
- France,
- U.K.,
- Germany
- Italy.
The report covers the present scenario and the growth prospects of the Europe Radiotherapy market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
1 INTRODUCTION
1.1. OVERVIEW OF THE EUROPE RADIOTHERAPY MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED
2 MARKET SEGMENTATION
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE EUROPE RADIOTHERAPY MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 MARKET TIME LINE
2.2.4 MARKET GUIDE
2.2.5 COMPANY POSITIONING GRID
2.2.6 COMAPANY MARKET SHARE ANALYSIS
2.2.7 MULTIVARIATE MODELLING
2.2.8 STANDARDS OF MEASUREMENT
2.2.9 TOP TO BOTTOM ANALYSIS
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3. EUROPE RADIOTHERAPY MARKET: RESEARCH SNAPSHOT
2.4. ASSUMPTIONS
3 MARKET OVERVIEW
3.1. DRIVERS
3.2. RESTRAINTS
3.3. OPPORTUNITIES
3.4. CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1. VENDOR POSITIONING GRID AND INVESTMENT OPPORTUNITIES
5.2. TECHNOLOLGICAL ADVANCEMENTS
5.3. INSIGHTS ON TECHNOLOGICAL DEVELOPMENTS IN THE EUROPE RADIOTHERAPY MARKET MARKET
5.4. MARKET REGULATORY SCENARIO BY COUNTRY
5.5. INTERVIEW KEY INSIGHTS
6 EUROPE RADIOTHERAPY MARKET, BY THERAPY
7 EUROPE RADIOTHERAPY MARKET, BY THERAPY
8 EUROPE RADIOTHERAPY MARKET, BY APLLICATION
9 EUROPE RADIOTHERAPY MARKET, BY TECHNOLOGY
10 EUROPE RADIOTHERAPY MARKET: GEOGRAPHY
11 EUROPE RADIOTHERAPY MARKET, COMPANY PROFILES
11.1 VARIAN MEDICAL SYSTEMS, INC.
11.2 CIVCO MEDICAL SOLUTIONS
11.3 ELEKTA AB
11.4 NANOBIOTIX
11.5 ACCURAY INCORPORATED,
11.6 COMPANY A
11.7 COMPANY B
11.8 COMPANY C
11.9 COMPANY D
11.10 COMPANY E
11.11 COMPANY F
11.12 COMPANY G
11.13 COMPANY H
11.14 COMPANY I
11.15 COMPANY J
11.16 COMPANY K
11.17 COMPANY M
11.18 COMPANY N
11.19 COMPANY O
12 APPENDIX
13 ABOUT DATA BRIDGE MARKET RESEARCH
1.1. OVERVIEW OF THE EUROPE RADIOTHERAPY MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED
2 MARKET SEGMENTATION
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE EUROPE RADIOTHERAPY MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 MARKET TIME LINE
2.2.4 MARKET GUIDE
2.2.5 COMPANY POSITIONING GRID
2.2.6 COMAPANY MARKET SHARE ANALYSIS
2.2.7 MULTIVARIATE MODELLING
2.2.8 STANDARDS OF MEASUREMENT
2.2.9 TOP TO BOTTOM ANALYSIS
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3. EUROPE RADIOTHERAPY MARKET: RESEARCH SNAPSHOT
2.4. ASSUMPTIONS
3 MARKET OVERVIEW
3.1. DRIVERS
3.2. RESTRAINTS
3.3. OPPORTUNITIES
3.4. CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1. VENDOR POSITIONING GRID AND INVESTMENT OPPORTUNITIES
5.2. TECHNOLOLGICAL ADVANCEMENTS
5.3. INSIGHTS ON TECHNOLOGICAL DEVELOPMENTS IN THE EUROPE RADIOTHERAPY MARKET MARKET
5.4. MARKET REGULATORY SCENARIO BY COUNTRY
5.5. INTERVIEW KEY INSIGHTS
6 EUROPE RADIOTHERAPY MARKET, BY THERAPY
7 EUROPE RADIOTHERAPY MARKET, BY THERAPY
8 EUROPE RADIOTHERAPY MARKET, BY APLLICATION
9 EUROPE RADIOTHERAPY MARKET, BY TECHNOLOGY
10 EUROPE RADIOTHERAPY MARKET: GEOGRAPHY
11 EUROPE RADIOTHERAPY MARKET, COMPANY PROFILES
11.1 VARIAN MEDICAL SYSTEMS, INC.
11.2 CIVCO MEDICAL SOLUTIONS
11.3 ELEKTA AB
11.4 NANOBIOTIX
11.5 ACCURAY INCORPORATED,
11.6 COMPANY A
11.7 COMPANY B
11.8 COMPANY C
11.9 COMPANY D
11.10 COMPANY E
11.11 COMPANY F
11.12 COMPANY G
11.13 COMPANY H
11.14 COMPANY I
11.15 COMPANY J
11.16 COMPANY K
11.17 COMPANY M
11.18 COMPANY N
11.19 COMPANY O
12 APPENDIX
13 ABOUT DATA BRIDGE MARKET RESEARCH
